Announcement of NMPA and the National Health Commission on the Quality Management Of Clinical Trials for Medical Devices (No. 28, 2022)
- Categories:News
- Author:
- Origin:
- Time of issue:2022-04-07
- Views:0
(Summary description)
Announcement of NMPA and the National Health Commission on the Quality Management Of Clinical Trials for Medical Devices (No. 28, 2022)
(Summary description)
- Categories:News
- Author:
- Origin:
- Time of issue:2022-04-07
- Views:0
To deepen the reform of the medical device review and approval system and strengthen the management of clinical trials of medical devices, in accordance with the Regulations on the Supervision and Administration of Medical Devices (Order No. 739 of the State Council), the Administrative Measures for the Registration and Filing of Medical Devices (Order No. 47 of the State Administration for Market Regulation), and the Administrative Measures for the Registration and Filing of In Vitro Diagnostic Reagents (Order No. 48 of the State Administration for Market Regulation), NMPA, together with the National Health Commission, has revised the Quality Management Of Clinical Trials for Medical Devices (No. 28, 2022), which is hereby promulgated. Effective as of May 1, 2022.
This is hereby announced.国家药监局 国家卫生健康委关于发布《医疗器械临床试验质量管理规范》的公告(2022年第28号) (nmpa.gov.cn)
Scan the QR code to read on your phone
Recommended News


Telephones

info@crcs.com.cn

Address
Room 1009, Tower A, Longqin International Building, No. 168, Guang 'anmenwai Street, Xicheng District, Beijing
Company Introduction
The company specializes in medical device registration, in vitro diagnostic reagents registration, cosmetics agent service company, committed to the NMPA, CE regulation research and product registration and certification service has been more than 17 years.
Contact us
Beijing Medical & Care Co. Ltd.